Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment

被引:9
|
作者
Gjoni, Tina [1 ]
Urwyler, Stephan [1 ]
机构
[1] Novartis Inst Biomed Res, Basel, Switzerland
关键词
GABA(B) receptor; Constitutive activity; Inverse agonism; Allosteric modulator; Desensitization; Ligand property; Efficacy; PROTEIN-COUPLED RECEPTORS; MU-OPIOID-RECEPTOR; INVERSE AGONISTS; CONSTITUTIVE ACTIVITY; N,N'-DICYCLOPENTYL-2-METHYLSULFANYL-5-NITRO-PYRIMIDINE-4,6-DIAMINE GS39783; NEUTRAL ANTAGONISTS; HEPTAHELICAL DOMAIN; SIGNALING PROTEINS; POINT MUTATIONS; 2-STATE MODEL;
D O I
10.1016/j.ejphar.2008.12.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been estimated that only 15% of the compounds classified as silent G protein-coupled receptor antagonists are indeed devoid of either positive or negative intrinsic efficacy. Considering that 40% of all drugs on the market target G protein-coupled receptors mainly as orthosteric ligands, elucidating their intrinsic properties is becoming increasingly important. While agonism can be demonstrated using appropriately sensitive experimental setups, the detection of inverse agonism can be limited by a low degree of constitutive activity in many assay systems. In this study, changes in ligand behavior upon a lasting pretreatment with gamma-aminobutyric acid (GAB(B)), that induced receptor desensitization, were observed, measuring the second messenger cyclic AMP (cAMP) in a GABA(B) receptor-expressing recombinant cell line. The GABA(B) receptor partial agonist 2-OH-saclofen lost its ability to inhibit 7 beta-forskolin-induced cAMP production upon GAB(A)-pretreatment. The "silent" receptor antagonists CGP62349, CGP52432, CGP56999 and SCH50911, on the other hand, stimulated 7 beta-forskolin-induced cAMP production under these conditions. The inverse agonism of CGP56999 was inhibited by the efficacy-deficient 2-OH-saclofen, proving it was truly mediated through the orthosteric site of the GABA(B) receptor. Finally, the positive allosteric modulator GS39783, which previously only marginally inhibited cAMP production, suppressed it by 60% both alone and in the presence of the competitive receptor antagonist 2-OH-saclofen, thus GS39783 became an allosteric receptor agonist at desensitized GABA(B) receptors. These changes likely reflect adaptations in the mechanisms of GABA(B) receptor function following desensitization and may be important in the elucidation of intrinsic ligand efficacies as well as for the consequences of continuous drug treatment. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 50 条
  • [1] Muscarinic receptor interaction of novel allosteric/orthosteric antagonist ligands
    Kaufel, D.
    Schmitz, J.
    Holzgrabe, U.
    Mohr, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 14 - 14
  • [2] Efficacy at the Mu Opioid Receptor: Insights from Orthosteric and Allosteric Ligands
    Livingston, Kathryn E.
    Mahoney, Jacob
    Manglik, Aashish
    Kobilka, Brian
    Sunahara, Roger
    Traynor, John R.
    FASEB JOURNAL, 2016, 30
  • [3] New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
    Ferrisi, Rebecca
    Polini, Beatrice
    Ricardi, Caterina
    Gado, Francesca
    Mohamed, Kawthar A. A.
    Baron, Giovanna
    Faiella, Salvatore
    Poli, Giulio
    Rapposelli, Simona
    Saccomanni, Giuseppe
    Aldini, Giancarlo
    Chiellini, Grazia
    Laprairie, Robert B. B.
    Manera, Clementina
    Ortore, Gabriella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [4] Regulation of the M1 muscarinic acetylcholine receptor by orthosteric and allosteric ligands
    Thomas, R.
    Langmead, C.
    Wood, M.
    Challiss, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 28 - 28
  • [5] Molecular determinants involved in the allosteric control of agonist affinity in the GABAB receptor by the GABAB2 subunit
    Liu, JF
    Maurel, D
    Etzol, S
    Brabet, I
    Ansanay, H
    Pin, JP
    Rondard, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) : 15824 - 15830
  • [6] Binding of orthosteric ligands to the allosteric site of the M2 muscarinic cholinergic receptor
    Redka, Dar'ya S.
    Pisterzi, Luca F.
    Wells, James W.
    MOLECULAR PHARMACOLOGY, 2008, 74 (03) : 834 - 843
  • [7] Differential Regulation of the M1 Muscarinic Acetylcholine Receptor by Orthosteric and Allosteric Ligands
    Thomas, Rachel
    Langmead, Christopher
    Wood, Martyn
    Challiss, John
    FASEB JOURNAL, 2008, 22
  • [8] Extracellular Calcium Modulates Actions of Orthosteric and Allosteric Ligands on Metabotropic Glutamate Receptor 1α
    Jiang, Jason Y.
    Nagaraju, Mulpuri
    Meyer, Rebecca C.
    Zhang, Li
    Hamelberg, Donald
    Hall, Randy A.
    Brown, Edward M.
    Conn, P. Jeffrey
    Yang, Jenny J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (03) : 1649 - 1661
  • [9] Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition
    Amanda J. Kennedy
    Linda Sundström
    Stefan Geschwindner
    Eunice K. Y. Poon
    Yuhong Jiang
    Rongfeng Chen
    Rob Cooke
    Shawn Johnstone
    Andrew Madin
    Junxian Lim
    Qingqi Liu
    Rink-Jan Lohman
    Anneli Nordqvist
    Maria Fridén-Saxin
    Wenzhen Yang
    Dean G. Brown
    David P. Fairlie
    Niek Dekker
    Communications Biology, 3
  • [10] Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition
    Kennedy, Amanda J.
    Sundstrom, Linda
    Geschwindner, Stefan
    Poon, Eunice K. Y.
    Jiang, Yuhong
    Chen, Rongfeng
    Cooke, Rob
    Johnstone, Shawn
    Madin, Andrew
    Lim, Junxian
    Liu, Qingqi
    Lohman, Rink-Jan
    Nordqvist, Anneli
    Friden-Saxin, Maria
    Yang, Wenzhen
    Brown, Dean G.
    Fairlie, David P.
    Dekker, Niek
    COMMUNICATIONS BIOLOGY, 2020, 3 (01)